Trials / Completed
CompletedNCT02362087
Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer
A Multi-Centre Study to Investigate the Natural History of Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (actual)
- Sponsor
- Ottawa Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to document what course of action physicians choose for their patients when they develop taxane acute pain syndrome (TAPS) and to identify patients at the greatest risk of TAPS by examining specific human genome markers such as single nucleotide polymorphisms (SNPs) and Copy Number Variations (CNVs) that may explain the genetic (hereditary) component.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Quality of life and brief pain inventory | blood collection and quality of life questionnaires and a pain medication diary |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-02-12
- Last updated
- 2019-09-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02362087. Inclusion in this directory is not an endorsement.